Insider Transactions in Q2 2022 at Harvard Bioscience Inc (HBIO)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2022
|
James W Green Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
30,000
+1.29%
|
$90,000
$3.71 P/Share
|
|
Jun 11
2022
|
James W Green Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
48,373
-2.09%
|
$145,119
$3.95 P/Share
|
|
Jun 11
2022
|
Michael A. Rossi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,325
-2.23%
|
$18,975
$3.95 P/Share
|
|
May 24
2022
|
Katherine A. Eade Director |
BUY
Grant, award, or other acquisition
|
Direct |
38,259
+13.76%
|
-
|
|
May 24
2022
|
Alan I Edrick Director |
BUY
Grant, award, or other acquisition
|
Direct |
38,259
+18.15%
|
-
|
|
May 24
2022
|
Thomas W Loewald Director |
BUY
Grant, award, or other acquisition
|
Direct |
38,259
+14.59%
|
-
|
|
May 24
2022
|
Bertrand Loy Director |
BUY
Grant, award, or other acquisition
|
Direct |
47,493
+12.25%
|
-
|
|
May 09
2022
|
James W Green Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+0.43%
|
$30,000
$3.4 P/Share
|
|
May 06
2022
|
James W Green Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
30,000
+1.28%
|
$90,000
$3.78 P/Share
|